nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLC15A2—melanoma	0.296	0.704	CbGaD
Glyburide—ABCC1—Vemurafenib—melanoma	0.0776	0.192	CbGbCtD
Glyburide—ALB—melanoma	0.0637	0.151	CbGaD
Glyburide—ABCB1—melanoma	0.0608	0.145	CbGaD
Glyburide—ABCG2—Vemurafenib—melanoma	0.052	0.129	CbGbCtD
Glyburide—ABCC1—Dactinomycin—melanoma	0.0516	0.128	CbGbCtD
Glyburide—ALB—Vemurafenib—melanoma	0.0358	0.0886	CbGbCtD
Glyburide—ABCG2—Dactinomycin—melanoma	0.0345	0.0854	CbGbCtD
Glyburide—SLC22A7—Docetaxel—melanoma	0.0339	0.084	CbGbCtD
Glyburide—ABCC1—Docetaxel—melanoma	0.0266	0.0659	CbGbCtD
Glyburide—CYP3A4—Temozolomide—melanoma	0.0205	0.0507	CbGbCtD
Glyburide—ABCC2—Docetaxel—melanoma	0.0197	0.0488	CbGbCtD
Glyburide—ABCG2—Docetaxel—melanoma	0.0178	0.0441	CbGbCtD
Glyburide—ABCB1—Dactinomycin—melanoma	0.0124	0.0308	CbGbCtD
Glyburide—CYP3A4—Vemurafenib—melanoma	0.0112	0.0278	CbGbCtD
Glyburide—ABCB1—Docetaxel—melanoma	0.00643	0.0159	CbGbCtD
Glyburide—CYP3A4—Docetaxel—melanoma	0.00385	0.00953	CbGbCtD
Glyburide—KCNJ1—appendage—melanoma	0.00261	0.199	CbGeAlD
Glyburide—Myelosuppression—Bleomycin—melanoma	0.00153	0.023	CcSEcCtD
Glyburide—Myelosuppression—Dactinomycin—melanoma	0.00142	0.0214	CcSEcCtD
Glyburide—ABCA1—blood vessel—melanoma	0.00138	0.105	CbGeAlD
Glyburide—Myelosuppression—Carmustine—melanoma	0.00133	0.0201	CcSEcCtD
Glyburide—Myelosuppression—Temozolomide—melanoma	0.00129	0.0194	CcSEcCtD
Glyburide—Vasculitis—Vemurafenib—melanoma	0.00121	0.0182	CcSEcCtD
Glyburide—Reaction gastrointestinal—Docetaxel—melanoma	0.0012	0.0181	CcSEcCtD
Glyburide—Eruption—Dactinomycin—melanoma	0.00109	0.0163	CcSEcCtD
Glyburide—Encephalopathy—Carmustine—melanoma	0.000974	0.0146	CcSEcCtD
Glyburide—Digestion impaired—Temozolomide—melanoma	0.000904	0.0136	CcSEcCtD
Glyburide—Arthritis—Vemurafenib—melanoma	0.000883	0.0133	CcSEcCtD
Glyburide—Coagulopathy—Dactinomycin—melanoma	0.000858	0.0129	CcSEcCtD
Glyburide—Myelosuppression—Docetaxel—melanoma	0.000857	0.0129	CcSEcCtD
Glyburide—KCNJ5—head—melanoma	0.000813	0.0618	CbGeAlD
Glyburide—Cholestasis—Temozolomide—melanoma	0.000795	0.012	CcSEcCtD
Glyburide—CPT1A—eye—melanoma	0.00079	0.0601	CbGeAlD
Glyburide—Coagulopathy—Temozolomide—melanoma	0.000776	0.0117	CcSEcCtD
Glyburide—Eosinophilia—Vemurafenib—melanoma	0.000734	0.011	CcSEcCtD
Glyburide—Gliclazide—VEGFA—melanoma	0.000716	0.265	CrCbGaD
Glyburide—Chlorpropamide—SLC15A2—melanoma	0.000696	0.258	CrCbGaD
Glyburide—Photosensitivity reaction—Vemurafenib—melanoma	0.000677	0.0102	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Temozolomide—melanoma	0.000664	0.00999	CcSEcCtD
Glyburide—Eruption—Docetaxel—melanoma	0.000653	0.00982	CcSEcCtD
Glyburide—ABCA1—skin of body—melanoma	0.00064	0.0487	CbGeAlD
Glyburide—Aplastic anaemia—Dactinomycin—melanoma	0.000627	0.00943	CcSEcCtD
Glyburide—Heartburn—Docetaxel—melanoma	0.000584	0.00878	CcSEcCtD
Glyburide—Aplastic anaemia—Temozolomide—melanoma	0.000567	0.00853	CcSEcCtD
Glyburide—Eye disorder—Vemurafenib—melanoma	0.000555	0.00834	CcSEcCtD
Glyburide—Glipizide—PPARG—melanoma	0.000551	0.204	CrCbGaD
Glyburide—Hepatic failure—Dactinomycin—melanoma	0.000539	0.00812	CcSEcCtD
Glyburide—Arthritis—Bleomycin—melanoma	0.000535	0.00805	CcSEcCtD
Glyburide—Alopecia—Vemurafenib—melanoma	0.000524	0.00789	CcSEcCtD
Glyburide—Erythema—Vemurafenib—melanoma	0.000517	0.00777	CcSEcCtD
Glyburide—Malnutrition—Vemurafenib—melanoma	0.000517	0.00777	CcSEcCtD
Glyburide—ABCC1—hair follicle—melanoma	0.000512	0.0389	CbGeAlD
Glyburide—Deafness—Temozolomide—melanoma	0.00049	0.00737	CcSEcCtD
Glyburide—Vascular purpura—Temozolomide—melanoma	0.00049	0.00737	CcSEcCtD
Glyburide—Hepatic failure—Temozolomide—melanoma	0.000488	0.00734	CcSEcCtD
Glyburide—Hyponatraemia—Carmustine—melanoma	0.000456	0.00685	CcSEcCtD
Glyburide—Purpura—Temozolomide—melanoma	0.000455	0.00684	CcSEcCtD
Glyburide—Diplopia—Carmustine—melanoma	0.000454	0.00683	CcSEcCtD
Glyburide—CPT1A—head—melanoma	0.000448	0.0341	CbGeAlD
Glyburide—Hyperbilirubinaemia—Docetaxel—melanoma	0.000442	0.00665	CcSEcCtD
Glyburide—Arthralgia—Vemurafenib—melanoma	0.00044	0.00662	CcSEcCtD
Glyburide—Myalgia—Vemurafenib—melanoma	0.00044	0.00662	CcSEcCtD
Glyburide—KCNJ1—head—melanoma	0.000439	0.0334	CbGeAlD
Glyburide—Diplopia—Temozolomide—melanoma	0.000438	0.0066	CcSEcCtD
Glyburide—ABCC9—lymph node—melanoma	0.000432	0.0328	CbGeAlD
Glyburide—Pancytopenia—Bleomycin—melanoma	0.000427	0.00642	CcSEcCtD
Glyburide—ABCA1—head—melanoma	0.000418	0.0318	CbGeAlD
Glyburide—Nervous system disorder—Vemurafenib—melanoma	0.000414	0.00622	CcSEcCtD
Glyburide—Bezafibrate—PPARG—melanoma	0.000402	0.149	CrCbGaD
Glyburide—Pancytopenia—Dactinomycin—melanoma	0.000398	0.00599	CcSEcCtD
Glyburide—CFTR—head—melanoma	0.000395	0.03	CbGeAlD
Glyburide—Hypotension—Vemurafenib—melanoma	0.000394	0.00593	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000384	0.00578	CcSEcCtD
Glyburide—Abdominal distension—Temozolomide—melanoma	0.000381	0.00574	CcSEcCtD
Glyburide—Pancytopenia—Carmustine—melanoma	0.000372	0.0056	CcSEcCtD
Glyburide—Sweating increased—Temozolomide—melanoma	0.000369	0.00555	CcSEcCtD
Glyburide—Decreased appetite—Vemurafenib—melanoma	0.000367	0.00551	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000364	0.00548	CcSEcCtD
Glyburide—Pancytopenia—Temozolomide—melanoma	0.00036	0.00541	CcSEcCtD
Glyburide—Agranulocytosis—Dactinomycin—melanoma	0.000349	0.00524	CcSEcCtD
Glyburide—Photosensitivity reaction—Temozolomide—melanoma	0.000346	0.0052	CcSEcCtD
Glyburide—Hepatitis—Dactinomycin—melanoma	0.000335	0.00505	CcSEcCtD
Glyburide—SLC15A1—mammalian vulva—melanoma	0.000328	0.0249	CbGeAlD
Glyburide—Deafness—Docetaxel—melanoma	0.000326	0.0049	CcSEcCtD
Glyburide—Hepatic failure—Docetaxel—melanoma	0.000324	0.00488	CcSEcCtD
Glyburide—Alopecia—Bleomycin—melanoma	0.000318	0.00478	CcSEcCtD
Glyburide—CPT1A—lymph node—melanoma	0.000314	0.0239	CbGeAlD
Glyburide—Erythema—Bleomycin—melanoma	0.000313	0.00471	CcSEcCtD
Glyburide—Hypersensitivity—Vemurafenib—melanoma	0.000311	0.00467	CcSEcCtD
Glyburide—Visual disturbance—Docetaxel—melanoma	0.000308	0.00463	CcSEcCtD
Glyburide—Renal impairment—Docetaxel—melanoma	0.000306	0.00461	CcSEcCtD
Glyburide—Dermatitis bullous—Docetaxel—melanoma	0.000305	0.00459	CcSEcCtD
Glyburide—Hepatitis—Temozolomide—melanoma	0.000303	0.00456	CcSEcCtD
Glyburide—Asthenia—Vemurafenib—melanoma	0.000303	0.00455	CcSEcCtD
Glyburide—Visual impairment—Carmustine—melanoma	0.000302	0.00455	CcSEcCtD
Glyburide—Pruritus—Vemurafenib—melanoma	0.000298	0.00449	CcSEcCtD
Glyburide—Alopecia—Dactinomycin—melanoma	0.000296	0.00446	CcSEcCtD
Glyburide—Eye disorder—Carmustine—melanoma	0.000293	0.00441	CcSEcCtD
Glyburide—Hyponatraemia—Docetaxel—melanoma	0.000293	0.0044	CcSEcCtD
Glyburide—ABCA1—lymph node—melanoma	0.000293	0.0222	CbGeAlD
Glyburide—Visual impairment—Temozolomide—melanoma	0.000292	0.0044	CcSEcCtD
Glyburide—Erythema—Dactinomycin—melanoma	0.000292	0.00439	CcSEcCtD
Glyburide—Anaemia—Bleomycin—melanoma	0.000289	0.00435	CcSEcCtD
Glyburide—Diarrhoea—Vemurafenib—melanoma	0.000289	0.00434	CcSEcCtD
Glyburide—Eye disorder—Temozolomide—melanoma	0.000283	0.00426	CcSEcCtD
Glyburide—Leukopenia—Bleomycin—melanoma	0.00028	0.00422	CcSEcCtD
Glyburide—Alopecia—Carmustine—melanoma	0.000277	0.00417	CcSEcCtD
Glyburide—Malnutrition—Carmustine—melanoma	0.000273	0.00411	CcSEcCtD
Glyburide—Erythema—Carmustine—melanoma	0.000273	0.00411	CcSEcCtD
Glyburide—Anaemia—Dactinomycin—melanoma	0.00027	0.00406	CcSEcCtD
Glyburide—Vomiting—Vemurafenib—melanoma	0.000268	0.00403	CcSEcCtD
Glyburide—Alopecia—Temozolomide—melanoma	0.000268	0.00403	CcSEcCtD
Glyburide—Myalgia—Bleomycin—melanoma	0.000266	0.00401	CcSEcCtD
Glyburide—KCNJ11—head—melanoma	0.000266	0.0203	CbGeAlD
Glyburide—Rash—Vemurafenib—melanoma	0.000266	0.004	CcSEcCtD
Glyburide—Dermatitis—Vemurafenib—melanoma	0.000266	0.004	CcSEcCtD
Glyburide—Headache—Vemurafenib—melanoma	0.000264	0.00397	CcSEcCtD
Glyburide—Erythema—Temozolomide—melanoma	0.000264	0.00397	CcSEcCtD
Glyburide—Malnutrition—Temozolomide—melanoma	0.000264	0.00397	CcSEcCtD
Glyburide—Leukopenia—Dactinomycin—melanoma	0.000261	0.00393	CcSEcCtD
Glyburide—Confusional state—Bleomycin—melanoma	0.000258	0.00388	CcSEcCtD
Glyburide—Vision blurred—Carmustine—melanoma	0.000258	0.00387	CcSEcCtD
Glyburide—Tremor—Carmustine—melanoma	0.000256	0.00385	CcSEcCtD
Glyburide—SLC15A2—retina—melanoma	0.000256	0.0195	CbGeAlD
Glyburide—Oedema—Bleomycin—melanoma	0.000255	0.00384	CcSEcCtD
Glyburide—Anaemia—Carmustine—melanoma	0.000253	0.0038	CcSEcCtD
Glyburide—Nausea—Vemurafenib—melanoma	0.00025	0.00377	CcSEcCtD
Glyburide—Thrombocytopenia—Bleomycin—melanoma	0.00025	0.00376	CcSEcCtD
Glyburide—Vision blurred—Temozolomide—melanoma	0.000249	0.00374	CcSEcCtD
Glyburide—Myalgia—Dactinomycin—melanoma	0.000249	0.00374	CcSEcCtD
Glyburide—Tremor—Temozolomide—melanoma	0.000247	0.00372	CcSEcCtD
Glyburide—ABCC8—head—melanoma	0.000245	0.0187	CbGeAlD
Glyburide—Leukopenia—Carmustine—melanoma	0.000245	0.00368	CcSEcCtD
Glyburide—Anaemia—Temozolomide—melanoma	0.000244	0.00367	CcSEcCtD
Glyburide—Anorexia—Bleomycin—melanoma	0.000244	0.00366	CcSEcCtD
Glyburide—Angioedema—Temozolomide—melanoma	0.000241	0.00363	CcSEcCtD
Glyburide—Pancytopenia—Docetaxel—melanoma	0.000239	0.0036	CcSEcCtD
Glyburide—Hypotension—Bleomycin—melanoma	0.000239	0.00359	CcSEcCtD
Glyburide—Oedema—Dactinomycin—melanoma	0.000238	0.00358	CcSEcCtD
Glyburide—Convulsion—Carmustine—melanoma	0.000237	0.00356	CcSEcCtD
Glyburide—Leukopenia—Temozolomide—melanoma	0.000236	0.00356	CcSEcCtD
Glyburide—Thrombocytopenia—Dactinomycin—melanoma	0.000233	0.00351	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000233	0.0035	CcSEcCtD
Glyburide—Myalgia—Carmustine—melanoma	0.000233	0.0035	CcSEcCtD
Glyburide—Paraesthesia—Bleomycin—melanoma	0.000229	0.00345	CcSEcCtD
Glyburide—Convulsion—Temozolomide—melanoma	0.000229	0.00344	CcSEcCtD
Glyburide—Dyspnoea—Bleomycin—melanoma	0.000228	0.00343	CcSEcCtD
Glyburide—Anorexia—Dactinomycin—melanoma	0.000227	0.00342	CcSEcCtD
Glyburide—Confusional state—Carmustine—melanoma	0.000225	0.00338	CcSEcCtD
Glyburide—Arthralgia—Temozolomide—melanoma	0.000225	0.00338	CcSEcCtD
Glyburide—Myalgia—Temozolomide—melanoma	0.000225	0.00338	CcSEcCtD
Glyburide—Oedema—Carmustine—melanoma	0.000223	0.00335	CcSEcCtD
Glyburide—Decreased appetite—Bleomycin—melanoma	0.000222	0.00334	CcSEcCtD
Glyburide—Jaundice—Docetaxel—melanoma	0.000219	0.0033	CcSEcCtD
Glyburide—Thrombocytopenia—Carmustine—melanoma	0.000218	0.00328	CcSEcCtD
Glyburide—Confusional state—Temozolomide—melanoma	0.000217	0.00327	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000217	0.00327	CcSEcCtD
Glyburide—Oedema—Temozolomide—melanoma	0.000215	0.00324	CcSEcCtD
Glyburide—Anorexia—Carmustine—melanoma	0.000213	0.0032	CcSEcCtD
Glyburide—Nervous system disorder—Temozolomide—melanoma	0.000211	0.00318	CcSEcCtD
Glyburide—Thrombocytopenia—Temozolomide—melanoma	0.000211	0.00317	CcSEcCtD
Glyburide—Feeling abnormal—Bleomycin—melanoma	0.000211	0.00317	CcSEcCtD
Glyburide—Agranulocytosis—Docetaxel—melanoma	0.00021	0.00315	CcSEcCtD
Glyburide—Hypotension—Carmustine—melanoma	0.000208	0.00313	CcSEcCtD
Glyburide—Hyperhidrosis—Temozolomide—melanoma	0.000208	0.00313	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—melanoma	0.000207	0.00312	CcSEcCtD
Glyburide—ABCC3—head—melanoma	0.000206	0.0157	CbGeAlD
Glyburide—Anorexia—Temozolomide—melanoma	0.000205	0.00309	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Carmustine—melanoma	0.000203	0.00306	CcSEcCtD
Glyburide—Urticaria—Bleomycin—melanoma	0.000203	0.00305	CcSEcCtD
Glyburide—ABCC1—mammalian vulva—melanoma	0.000203	0.0154	CbGeAlD
Glyburide—Hepatitis—Docetaxel—melanoma	0.000202	0.00303	CcSEcCtD
Glyburide—Paraesthesia—Carmustine—melanoma	0.0002	0.00301	CcSEcCtD
Glyburide—Dyspnoea—Carmustine—melanoma	0.000199	0.00299	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—melanoma	0.000196	0.00295	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000196	0.00295	CcSEcCtD
Glyburide—ABCB1—blood vessel—melanoma	0.000196	0.0149	CbGeAlD
Glyburide—Gastrointestinal pain—Dactinomycin—melanoma	0.000195	0.00293	CcSEcCtD
Glyburide—Visual impairment—Docetaxel—melanoma	0.000194	0.00292	CcSEcCtD
Glyburide—Decreased appetite—Carmustine—melanoma	0.000194	0.00292	CcSEcCtD
Glyburide—Paraesthesia—Temozolomide—melanoma	0.000194	0.00291	CcSEcCtD
Glyburide—Gliclazide—ALB—melanoma	0.000193	0.0713	CrCbGaD
Glyburide—Gastrointestinal disorder—Carmustine—melanoma	0.000193	0.0029	CcSEcCtD
Glyburide—Dyspnoea—Temozolomide—melanoma	0.000192	0.00289	CcSEcCtD
Glyburide—SLCO2B1—head—melanoma	0.000192	0.0146	CbGeAlD
Glyburide—Dyspepsia—Temozolomide—melanoma	0.00019	0.00285	CcSEcCtD
Glyburide—Eye disorder—Docetaxel—melanoma	0.000189	0.00284	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—melanoma	0.000188	0.00283	CcSEcCtD
Glyburide—Hypersensitivity—Bleomycin—melanoma	0.000188	0.00283	CcSEcCtD
Glyburide—Decreased appetite—Temozolomide—melanoma	0.000187	0.00282	CcSEcCtD
Glyburide—KCNJ11—lymph node—melanoma	0.000186	0.0142	CbGeAlD
Glyburide—Gastrointestinal disorder—Temozolomide—melanoma	0.000186	0.0028	CcSEcCtD
Glyburide—Feeling abnormal—Carmustine—melanoma	0.000184	0.00276	CcSEcCtD
Glyburide—Asthenia—Bleomycin—melanoma	0.000183	0.00276	CcSEcCtD
Glyburide—Gastrointestinal pain—Carmustine—melanoma	0.000182	0.00274	CcSEcCtD
Glyburide—Pruritus—Bleomycin—melanoma	0.000181	0.00272	CcSEcCtD
Glyburide—Alopecia—Docetaxel—melanoma	0.000178	0.00268	CcSEcCtD
Glyburide—Feeling abnormal—Temozolomide—melanoma	0.000178	0.00267	CcSEcCtD
Glyburide—SLCO1A2—head—melanoma	0.000177	0.0134	CbGeAlD
Glyburide—Abdominal pain—Carmustine—melanoma	0.000176	0.00265	CcSEcCtD
Glyburide—Gastrointestinal pain—Temozolomide—melanoma	0.000176	0.00265	CcSEcCtD
Glyburide—Erythema—Docetaxel—melanoma	0.000176	0.00264	CcSEcCtD
Glyburide—Malnutrition—Docetaxel—melanoma	0.000176	0.00264	CcSEcCtD
Glyburide—Hypersensitivity—Dactinomycin—melanoma	0.000176	0.00264	CcSEcCtD
Glyburide—Urticaria—Temozolomide—melanoma	0.000171	0.00258	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—melanoma	0.000171	0.00257	CcSEcCtD
Glyburide—Abdominal pain—Temozolomide—melanoma	0.00017	0.00256	CcSEcCtD
Glyburide—ABCG2—mammalian vulva—melanoma	0.000168	0.0128	CbGeAlD
Glyburide—Hypersensitivity—Carmustine—melanoma	0.000164	0.00247	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—melanoma	0.000163	0.00245	CcSEcCtD
Glyburide—Vomiting—Bleomycin—melanoma	0.000162	0.00244	CcSEcCtD
Glyburide—Anaemia—Docetaxel—melanoma	0.000162	0.00244	CcSEcCtD
Glyburide—Rash—Bleomycin—melanoma	0.000161	0.00242	CcSEcCtD
Glyburide—Dermatitis—Bleomycin—melanoma	0.000161	0.00242	CcSEcCtD
Glyburide—Asthenia—Carmustine—melanoma	0.00016	0.00241	CcSEcCtD
Glyburide—Hypersensitivity—Temozolomide—melanoma	0.000159	0.00239	CcSEcCtD
Glyburide—Leukopenia—Docetaxel—melanoma	0.000157	0.00236	CcSEcCtD
Glyburide—Asthenia—Temozolomide—melanoma	0.000155	0.00233	CcSEcCtD
Glyburide—Diarrhoea—Carmustine—melanoma	0.000153	0.0023	CcSEcCtD
Glyburide—Pruritus—Temozolomide—melanoma	0.000152	0.00229	CcSEcCtD
Glyburide—Convulsion—Docetaxel—melanoma	0.000152	0.00229	CcSEcCtD
Glyburide—Nausea—Bleomycin—melanoma	0.000152	0.00228	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—melanoma	0.000151	0.00228	CcSEcCtD
Glyburide—Rash—Dactinomycin—melanoma	0.00015	0.00226	CcSEcCtD
Glyburide—Myalgia—Docetaxel—melanoma	0.000149	0.00225	CcSEcCtD
Glyburide—Arthralgia—Docetaxel—melanoma	0.000149	0.00225	CcSEcCtD
Glyburide—Diarrhoea—Temozolomide—melanoma	0.000147	0.00222	CcSEcCtD
Glyburide—SLC15A2—head—melanoma	0.000147	0.0112	CbGeAlD
Glyburide—Confusional state—Docetaxel—melanoma	0.000144	0.00217	CcSEcCtD
Glyburide—ABCC3—lymph node—melanoma	0.000144	0.011	CbGeAlD
Glyburide—Oedema—Docetaxel—melanoma	0.000143	0.00216	CcSEcCtD
Glyburide—Chlorpropamide—ABCB1—melanoma	0.000143	0.0529	CrCbGaD
Glyburide—Vomiting—Carmustine—melanoma	0.000142	0.00213	CcSEcCtD
Glyburide—Nausea—Dactinomycin—melanoma	0.000142	0.00213	CcSEcCtD
Glyburide—Shock—Docetaxel—melanoma	0.000141	0.00212	CcSEcCtD
Glyburide—Rash—Carmustine—melanoma	0.000141	0.00212	CcSEcCtD
Glyburide—Nervous system disorder—Docetaxel—melanoma	0.000141	0.00211	CcSEcCtD
Glyburide—Dermatitis—Carmustine—melanoma	0.00014	0.00211	CcSEcCtD
Glyburide—Thrombocytopenia—Docetaxel—melanoma	0.00014	0.00211	CcSEcCtD
Glyburide—Headache—Carmustine—melanoma	0.00014	0.0021	CcSEcCtD
Glyburide—Vomiting—Temozolomide—melanoma	0.000137	0.00206	CcSEcCtD
Glyburide—Anorexia—Docetaxel—melanoma	0.000137	0.00206	CcSEcCtD
Glyburide—Rash—Temozolomide—melanoma	0.000136	0.00204	CcSEcCtD
Glyburide—Dermatitis—Temozolomide—melanoma	0.000136	0.00204	CcSEcCtD
Glyburide—Headache—Temozolomide—melanoma	0.000135	0.00203	CcSEcCtD
Glyburide—SLCO2B1—lymph node—melanoma	0.000134	0.0102	CbGeAlD
Glyburide—Hypotension—Docetaxel—melanoma	0.000134	0.00201	CcSEcCtD
Glyburide—Nausea—Carmustine—melanoma	0.000132	0.00199	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000131	0.00196	CcSEcCtD
Glyburide—Paraesthesia—Docetaxel—melanoma	0.000129	0.00194	CcSEcCtD
Glyburide—Nausea—Temozolomide—melanoma	0.000128	0.00193	CcSEcCtD
Glyburide—Dyspnoea—Docetaxel—melanoma	0.000128	0.00192	CcSEcCtD
Glyburide—Dyspepsia—Docetaxel—melanoma	0.000126	0.0019	CcSEcCtD
Glyburide—Decreased appetite—Docetaxel—melanoma	0.000125	0.00187	CcSEcCtD
Glyburide—Gastrointestinal disorder—Docetaxel—melanoma	0.000124	0.00186	CcSEcCtD
Glyburide—ALB—lymph node—melanoma	0.000123	0.00936	CbGeAlD
Glyburide—Feeling abnormal—Docetaxel—melanoma	0.000118	0.00178	CcSEcCtD
Glyburide—Gastrointestinal pain—Docetaxel—melanoma	0.000117	0.00176	CcSEcCtD
Glyburide—ABCC2—lymph node—melanoma	0.000115	0.00877	CbGeAlD
Glyburide—Abdominal pain—Docetaxel—melanoma	0.000113	0.0017	CcSEcCtD
Glyburide—Hypersensitivity—Docetaxel—melanoma	0.000106	0.00159	CcSEcCtD
Glyburide—ABCB1—retina—melanoma	0.000103	0.00786	CbGeAlD
Glyburide—Asthenia—Docetaxel—melanoma	0.000103	0.00155	CcSEcCtD
Glyburide—SLC15A2—lymph node—melanoma	0.000103	0.00781	CbGeAlD
Glyburide—ABCC1—lymph node—melanoma	0.000102	0.00772	CbGeAlD
Glyburide—Pruritus—Docetaxel—melanoma	0.000101	0.00153	CcSEcCtD
Glyburide—Diarrhoea—Docetaxel—melanoma	9.81e-05	0.00148	CcSEcCtD
Glyburide—Vomiting—Docetaxel—melanoma	9.11e-05	0.00137	CcSEcCtD
Glyburide—Rash—Docetaxel—melanoma	9.04e-05	0.00136	CcSEcCtD
Glyburide—Dermatitis—Docetaxel—melanoma	9.03e-05	0.00136	CcSEcCtD
Glyburide—Headache—Docetaxel—melanoma	8.98e-05	0.00135	CcSEcCtD
Glyburide—Nausea—Docetaxel—melanoma	8.51e-05	0.00128	CcSEcCtD
Glyburide—ABCG2—lymph node—melanoma	8.41e-05	0.00639	CbGeAlD
Glyburide—ABCB1—mammalian vulva—melanoma	8.27e-05	0.00629	CbGeAlD
Glyburide—ABCB1—head—melanoma	5.92e-05	0.0045	CbGeAlD
Glyburide—ABCB1—lymph node—melanoma	4.14e-05	0.00315	CbGeAlD
Glyburide—ALB—Metabolism—VCAN—melanoma	5.37e-06	5.79e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PLA2G6—melanoma	5.37e-06	5.78e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—melanoma	5.36e-06	5.77e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—melanoma	5.33e-06	5.74e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PRKCA—melanoma	5.32e-06	5.74e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CG—melanoma	5.32e-06	5.73e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—melanoma	5.31e-06	5.72e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—melanoma	5.31e-06	5.72e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ERCC2—melanoma	5.28e-06	5.69e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PLA2G6—melanoma	5.24e-06	5.64e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CB—melanoma	5.22e-06	5.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLCB4—melanoma	5.17e-06	5.57e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—melanoma	5.17e-06	5.57e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOS2—melanoma	5.14e-06	5.54e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—melanoma	5.14e-06	5.53e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IGF1—melanoma	5.11e-06	5.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOTCH1—melanoma	5.09e-06	5.49e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ABCB1—melanoma	5.09e-06	5.48e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.08e-06	5.48e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	5.06e-06	5.45e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD80—melanoma	4.99e-06	5.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.98e-06	5.37e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KIT—melanoma	4.98e-06	5.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—melanoma	4.98e-06	5.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGF—melanoma	4.92e-06	5.3e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CD—melanoma	4.91e-06	5.29e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.91e-06	5.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PLA2G6—melanoma	4.89e-06	5.27e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CD—melanoma	4.88e-06	5.26e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC6A11—melanoma	4.86e-06	5.24e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIP4K2A—melanoma	4.86e-06	5.24e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.86e-06	5.24e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—VCAN—melanoma	4.82e-06	5.19e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.82e-06	5.19e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—melanoma	4.82e-06	5.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTAP—melanoma	4.73e-06	5.1e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—VCAN—melanoma	4.71e-06	5.07e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PRKCA—melanoma	4.68e-06	5.05e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—BRAF—melanoma	4.68e-06	5.04e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CD—melanoma	4.68e-06	5.04e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—melanoma	4.65e-06	5.01e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ERCC2—melanoma	4.65e-06	5.01e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—melanoma	4.63e-06	4.99e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—melanoma	4.62e-06	4.98e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.56e-06	4.92e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP17A1—melanoma	4.53e-06	4.88e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—melanoma	4.51e-06	4.86e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—melanoma	4.47e-06	4.82e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.47e-06	4.81e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAP2K1—melanoma	4.41e-06	4.75e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.41e-06	4.75e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—VCAN—melanoma	4.4e-06	4.74e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CD—melanoma	4.38e-06	4.72e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.37e-06	4.71e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—melanoma	4.34e-06	4.67e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—melanoma	4.34e-06	4.67e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GNA11—melanoma	4.28e-06	4.61e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CB—melanoma	4.28e-06	4.61e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CB—melanoma	4.25e-06	4.58e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LUM—melanoma	4.22e-06	4.54e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PHGDH—melanoma	4.22e-06	4.54e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—melanoma	4.21e-06	4.54e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGF2—melanoma	4.19e-06	4.51e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—FASN—melanoma	4.19e-06	4.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—melanoma	4.17e-06	4.49e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.16e-06	4.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPSE—melanoma	4.13e-06	4.45e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	4.13e-06	4.45e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC5A5—melanoma	4.12e-06	4.44e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—melanoma	4.08e-06	4.39e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—melanoma	4.07e-06	4.39e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.07e-06	4.39e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP17A1—melanoma	4.07e-06	4.38e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CUBN—melanoma	4.06e-06	4.37e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—melanoma	4.04e-06	4.35e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—melanoma	4.02e-06	4.34e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—melanoma	4.02e-06	4.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.02e-06	4.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.01e-06	4.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GNAQ—melanoma	3.98e-06	4.29e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CD44—melanoma	3.98e-06	4.29e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP17A1—melanoma	3.97e-06	4.28e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	3.96e-06	4.27e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—melanoma	3.93e-06	4.23e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MDM2—melanoma	3.92e-06	4.22e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CSPG4—melanoma	3.92e-06	4.22e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SDHD—melanoma	3.92e-06	4.22e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BSG—melanoma	3.92e-06	4.22e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.9e-06	4.2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—melanoma	3.87e-06	4.16e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.86e-06	4.16e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GNA11—melanoma	3.84e-06	4.14e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—melanoma	3.82e-06	4.11e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1B1—melanoma	3.81e-06	4.11e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—melanoma	3.81e-06	4.1e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPAM—melanoma	3.8e-06	4.09e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—melanoma	3.78e-06	4.07e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—FASN—melanoma	3.76e-06	4.05e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GNA11—melanoma	3.75e-06	4.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP17A1—melanoma	3.71e-06	4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC5A5—melanoma	3.7e-06	3.98e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	3.68e-06	3.96e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—melanoma	3.68e-06	3.96e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—melanoma	3.67e-06	3.95e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—FASN—melanoma	3.67e-06	3.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—melanoma	3.67e-06	3.95e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.66e-06	3.94e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—melanoma	3.62e-06	3.9e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	3.61e-06	3.89e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—melanoma	3.61e-06	3.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—melanoma	3.58e-06	3.86e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GNAQ—melanoma	3.57e-06	3.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CD44—melanoma	3.57e-06	3.85e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—melanoma	3.55e-06	3.83e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—melanoma	3.54e-06	3.82e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—melanoma	3.52e-06	3.8e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—melanoma	3.52e-06	3.79e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GNA11—melanoma	3.5e-06	3.77e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.5e-06	3.77e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GNAQ—melanoma	3.49e-06	3.76e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CD44—melanoma	3.49e-06	3.76e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.47e-06	3.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—FASN—melanoma	3.43e-06	3.69e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1B1—melanoma	3.42e-06	3.69e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—melanoma	3.38e-06	3.64e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—melanoma	3.37e-06	3.63e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.37e-06	3.63e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1B1—melanoma	3.34e-06	3.6e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—melanoma	3.34e-06	3.6e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—melanoma	3.3e-06	3.56e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—melanoma	3.3e-06	3.55e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—melanoma	3.3e-06	3.55e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—melanoma	3.28e-06	3.53e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GNAQ—melanoma	3.26e-06	3.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CD44—melanoma	3.26e-06	3.51e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLA2G6—melanoma	3.23e-06	3.48e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—melanoma	3.23e-06	3.47e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—melanoma	3.2e-06	3.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.19e-06	3.44e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—melanoma	3.18e-06	3.43e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—melanoma	3.18e-06	3.43e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—melanoma	3.17e-06	3.41e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.16e-06	3.4e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—melanoma	3.16e-06	3.4e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—melanoma	3.14e-06	3.38e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1B1—melanoma	3.12e-06	3.36e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—melanoma	3.07e-06	3.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.02e-06	3.26e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK1—melanoma	3.01e-06	3.24e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—melanoma	2.95e-06	3.18e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—melanoma	2.94e-06	3.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—VCAN—melanoma	2.9e-06	3.12e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PRKCA—melanoma	2.89e-06	3.11e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ERCC2—melanoma	2.87e-06	3.09e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—melanoma	2.84e-06	3.06e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—melanoma	2.82e-06	3.04e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—melanoma	2.82e-06	3.03e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—melanoma	2.81e-06	3.03e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—melanoma	2.79e-06	3e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—melanoma	2.76e-06	2.97e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.76e-06	2.97e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—melanoma	2.74e-06	2.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK1—melanoma	2.68e-06	2.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—melanoma	2.68e-06	2.89e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—melanoma	2.68e-06	2.89e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—melanoma	2.61e-06	2.81e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—melanoma	2.6e-06	2.8e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PRKCA—melanoma	2.6e-06	2.8e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—melanoma	2.59e-06	2.79e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ERCC2—melanoma	2.57e-06	2.77e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—melanoma	2.57e-06	2.77e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PRKCA—melanoma	2.53e-06	2.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—melanoma	2.53e-06	2.73e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—melanoma	2.52e-06	2.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ERCC2—melanoma	2.51e-06	2.71e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—melanoma	2.49e-06	2.68e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP17A1—melanoma	2.45e-06	2.64e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—melanoma	2.43e-06	2.62e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—melanoma	2.41e-06	2.6e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.37e-06	2.56e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PRKCA—melanoma	2.37e-06	2.55e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ERCC2—melanoma	2.35e-06	2.53e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—melanoma	2.33e-06	2.51e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNA11—melanoma	2.31e-06	2.49e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—melanoma	2.26e-06	2.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—FASN—melanoma	2.26e-06	2.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—melanoma	2.22e-06	2.4e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—melanoma	2.19e-06	2.35e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—melanoma	2.16e-06	2.33e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—melanoma	2.15e-06	2.32e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CD44—melanoma	2.15e-06	2.31e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNAQ—melanoma	2.15e-06	2.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.13e-06	2.3e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—melanoma	2.13e-06	2.3e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—melanoma	2.12e-06	2.28e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—melanoma	2.06e-06	2.22e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1B1—melanoma	2.06e-06	2.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—melanoma	2.03e-06	2.19e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—melanoma	2.03e-06	2.19e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—melanoma	1.99e-06	2.14e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—melanoma	1.98e-06	2.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—melanoma	1.96e-06	2.11e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—melanoma	1.95e-06	2.1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.94e-06	2.09e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—melanoma	1.91e-06	2.06e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—melanoma	1.9e-06	2.05e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—melanoma	1.85e-06	2e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—melanoma	1.79e-06	1.93e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—melanoma	1.79e-06	1.92e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—melanoma	1.77e-06	1.9e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—melanoma	1.76e-06	1.9e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—melanoma	1.74e-06	1.88e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—melanoma	1.74e-06	1.87e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—melanoma	1.72e-06	1.85e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—melanoma	1.72e-06	1.85e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—melanoma	1.71e-06	1.85e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—melanoma	1.7e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—melanoma	1.63e-06	1.76e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—melanoma	1.61e-06	1.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—melanoma	1.59e-06	1.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PRKCA—melanoma	1.56e-06	1.68e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—melanoma	1.56e-06	1.68e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ERCC2—melanoma	1.55e-06	1.67e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—melanoma	1.54e-06	1.66e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—melanoma	1.52e-06	1.64e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—melanoma	1.51e-06	1.62e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—melanoma	1.5e-06	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—melanoma	1.42e-06	1.53e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—melanoma	1.41e-06	1.52e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—melanoma	1.4e-06	1.51e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—melanoma	1.35e-06	1.45e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—melanoma	1.31e-06	1.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—melanoma	1.23e-06	1.32e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—melanoma	1.22e-06	1.32e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—melanoma	1.18e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—melanoma	1.07e-06	1.16e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—melanoma	1.06e-06	1.14e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—melanoma	1.06e-06	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—melanoma	9.49e-07	1.02e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—melanoma	9.37e-07	1.01e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—melanoma	9.28e-07	1e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—melanoma	9.27e-07	9.98e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—melanoma	8.66e-07	9.33e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—melanoma	8.64e-07	9.31e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—melanoma	8.09e-07	8.72e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—melanoma	7.76e-07	8.36e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—melanoma	7.57e-07	8.15e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—melanoma	7.07e-07	7.62e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—melanoma	5.71e-07	6.15e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—melanoma	4.66e-07	5.02e-06	CbGpPWpGaD
